dihydrostreptomycin is an approved drug
Compound class:
Synthetic organic
Comment: Dihydrostreptomycin is an aminoglycoside antibacterial drug and a derivative of streptomycin [1].
|
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes |
Withdrawn drug? | Yes |
International Nonproprietary Names | |
INN number | INN |
1574 | dihydrostreptomycin |
Database Links | |
Specialist databases | |
Antibiotic DB | Dihydrostreptomycin |
Other databases | |
CAS Registry No. | 128-46-1 (source: Scifinder) |
ChEBI | CHEBI:38291 |
ChEMBL Ligand | CHEMBL1950576 |
DrugBank Ligand | DB11512 |
DrugCentral Ligand | 890 |
GtoPdb PubChem SID | 472319285 |
PubChem CID | 439369 |
RCSB PDB Ligand | 71R |
Search Google for chemical match using the InChIKey | ASXBYYWOLISCLQ-HZYVHMACSA-N |
Search Google for chemicals with the same backbone | ASXBYYWOLISCLQ |
Search PubMed clinical trials | dihydrostreptomycin |
Search PubMed titles | dihydrostreptomycin |
Search PubMed titles/abstracts | dihydrostreptomycin |
UniChem Compound Search for chemical match using the InChIKey | ASXBYYWOLISCLQ-HZYVHMACSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ASXBYYWOLISCLQ-HZYVHMACSA-N |